Mapping immune responses to mRBP-3 1-16 peptide with altered peptide ligands

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 5, 2006, Pages 2027-2035

  Guyver, Carly J ^a   Copland, David A ^a   Calder, Claudia J ^a   Sette, Alessandro ^b   Sidney, John ^b   Dick, Andrew D ^a   Nicholson, Lindsay B ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERED PEPTIDE LIGAND; INTERPHOTORECEPTOR RETINOID BINDING PROTEIN; LIGAND; PROTEIN MRBP 3; PROTEIN SUBUNIT; RETINOID BINDING PROTEIN; T LYMPHOCYTE RECEPTOR; THYMIDINE; UNCLASSIFIED DRUG; CYTOKINE; EPITOPE; EYE PROTEIN; HLA ANTIGEN CLASS 2; I A(B) ANTIGEN, MOUSE; I-A(B) ANTIGEN, MOUSE; LYMPHOCYTE ANTIGEN RECEPTOR; PEPTIDE FRAGMENT; RETINOL BINDING PROTEIN; RETINOL-BINDING GLYCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; C57BL 6 MOUSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE CLONE; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PEPTIDE MAPPING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; T LYMPHOCYTE; TH1 CELL; UVEORETINITIS; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; IMMUNIZATION; IMMUNOLOGY; LYMPH NODE; LYMPHOCYTE ACTIVATION; PATHOLOGY; RETINITIS; UVEITIS;

ANIMALS; AUTOIMMUNE DISEASES; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; EYE PROTEINS; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNIZATION; LIGANDS; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; PEPTIDE FRAGMENTS; RECEPTORS, ANTIGEN, T-CELL; RETINITIS; RETINOL-BINDING PROTEINS; TH1 CELLS; UVEITIS;

EID: 33744755995     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-0984     Document Type: Article

References (26)

1. Faure JP. Autoimmunity and the retina. Curr Top Eye Res. 1980;2:215-302.
2. Caspi RR, Roberge FG, McAllister CG, et al. T cell lines mediating experimental autoimmune uveoretinitis (EAU) in the rat. J Immunol. 1986;136:928-933.
3. Borst DE, Redmond TM, Elser JE, et al. Interphotoreceptor retinoid-binding protein: gene characterization, protein repeat structure, and its evolution. J Biol Chem. 1989;264:1115-1123.
4. Avichezer D, Silver PB, Chan CC, et al. Identification of a new epitope of human IRBP that induces autoimmune uveoretinitis in mice of the H-2b haplotype. Invest Ophthalmol Vis Sci. 2000;41:127-131.
5. Egwuagu CE, Charukamnoetkanok P, Gery I. Thymic expression of autoantigens correlates with resistance to autoimmune disease. J Immunol. 1997;159:3109-3112.
6. Avichezer D, Liou GI, Chan CC, et al. Interphotoreceptor retinoid-binding protein (IRBP)-deficient C57BL/6 mice have enhanced immunological and immunopathogenic responses to IRBP and an altered recognition of IRBP epitopes. J Autoimmun. 2003;21:185-194.
7. Dick AD, Carter D, Robertson M, et al. Control of myeloid activity during retinal inflammation. J Leukoc Biol. 2003;74:161-166.
8. Dick AD, Cheng YF, Liversidge J, Forrester JV. Immunomodulation of experimental autoimmune uveoretinitis: a model of tolerance induction with retinal antigens. Eye. 1994;8:52-59.
9. Zhu Y, Rudensky AY, Corper AL, et al. Crystal structure of MHC class II I-Ab in complex with a human CLIP peptide: prediction of an I-Ab peptide-binding motif. J Mol Biol. 2003;326:1157-1174.
10. Janeway CA Jr, Conrad PJ, Lerner EA, et al. Monoclonal antibodies specific for Ia glycoproteins raised by immunization with activated T cells: possible role of T cellbound Ia antigens as targets of immunoregulatory T cells. J Immunol. 1984;132:662-667.
11. Sidney J, Southwood S, Oseroff C, et al. Current Protocols in Immunology. New York: John Wiley & Sons, Inc.; 1998:18.3.1-18.3.19.
12. Sette A, Sidney J, Albertson M, et al. A novel approach to the generation of high affinity class II-binding peptides. J Immunol. 1990;145:1809-1813.
13. Wall KA, Hu JY, Currier P, et al. A disease-related epitope of Torpedo acetylcholine receptor: residues involved in I-Ab binding, self-nonself discrimination, and TCR antagonism. J Immunol. 1994;152:4526-4536.
14. Avichezer D, Chan CC, Silver PB, et al. Residues 1-20 of IRBP and whole IRBP elicit different uveitogenic and immunological responses in interferon gamma deficient mice. Exp Eye Res. 2000;71:111-118.
15. Taylor N, McConachie K, Calder C, et al. Enhanced tolerance to autoimmune uveitis in CD200-deficient mice correlates with a pronounced Th2 switch in response to antigen challenge. J Immunol. 2005;174:143-154.
16. Liu GY, Fairchild PJ, Smith RM, et al. Low avidity recognition of self-antigen by T cells permits escape from central tolerance. Immunity. 1995;3:407-415.
17. Nicholson MJ, Hahn M, Wucherpfennig KW. Unusual features of self-peptide/MHC binding by autoimmune T cell receptors. Immunity. 2005;23:351-360.
18. Unanue ER. Chemical features of peptide selection by the class II histocompatibility molecules. Am J Pathol. 1999;154:651-664.
19. Avichezer D, Grajewski RS, Chan CC, et al. An immunologically privileged retinal antigen elicits tolerance: major role for central selection mechanisms. J Exp Med. 2003;198:1665-1676.
20. Anderton SM, Viner NJ, Matharu P, et al. Influence of a dominant cryptic epitope on autoimmune T cell tolerance. Nat Immunol. 2002;3:175-181.
21. Seamons A, Sutton J, Bai D, et al. Competition between two MHC binding registers in a single peptide processed from myelin basic protein influences tolerance and susceptibility to autoimmunity. J Exp Med. 2003;197:1391-1397.
22. Nicholson LB, Greer JM, Sobel RA, et al. An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity. 1995;3:397-405.
23. Nicholson LB, Waldner H, Carrizosa AM, et al. Heteroclitic proliferative responses and changes in cytokine profile induced by altered peptides: implications for autoimmunity. Proc Natl Acad Sci USA. 1998;95:264-269.
24. Wraith DC, Smilek DE, Mitchell DJ, et al. Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy. Cell. 1989;59:247-255.
25. Margot CD, Ford ML, Evavold BD. Amelioration of established experimental autoimmune encephalomyelitis by an MHC anchor-substituted variant of proteolipid protein 139-151. J Immunol. 2005;174:3352-3358.
26. Baron JL, Madri JA, Ruddle NH, et al. Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J Exp Med. 1993;177:57-68.